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Immunostimulants and vaccines are important for controlling infectious diseases in fish
aquaculture. In this study we assess the potential of flagellin to be used for such purposes
in rainbow trout (Oncorhynchus mykiss). A recombinant flagellin from the salmonid
pathogen Yersinia ruckeri (YRF) has been produced previously by us and shown to be
a potent activator of inflammatory cytokines, acute phase proteins and antimicrobial
peptides in vitro. Here we show that YRF is the most potent inflammatory activator of
three bacterial PAMPs (LPS, peptidoglycan and flagellin) tested. The host response to
flagellin was next studied in vivo. The YRF modulated gene expression was examined in
two systemic (spleen and liver) and two mucosa-associated (gills and skin) tissues. YRF
injection initiated a transient systemic inflammatory response with key pro-inflammatory
cytokines (IL-1β, TNFα, IL-6, and IL-11 etc.) and chemokines (CXCL_F4 and CXCL-8)
induced rapidly (by 6 h) but subsiding quickly (by 24 h) in multiple tissues. Consequently, a
variety of anti-microbial pathwayswere activated systemically with heightened expression
of acute phase proteins, antimicrobial peptides and complement genes in multiple
tissues, which was sustained to 24 h in the liver and mucosal tissues. The Th17
cytokine IL-17A/F1 was also induced in the spleen and liver, and Th2 cytokine IL-4/13
was induced in the liver. However, the anti-inflammatory IL-10 and the Th1 cytokine
IFNγ were refractory. A secreted form of TLR5 (TLR5s) was induced by flagellin in all
tissues examined whilst the membrane form was refractory, suggesting that TLR5s may
function as a negative feedback regulator. Trout liver appeared to be an important organ
responding to flagellin stimulation, with marked induction of IL-11, IL-23P19, IL-17C1,
SAA, and cathelicidin-2. YRF induced a strong antibody response. These antibodies
reacted against the middle domain of YRF and were able to decrease YRF bioactivity.
Intact YRF was necessary for its bioactivity, as deletion of the N-terminal, C terminal or
middle domain of YRF led to functional loss. This study suggests that flagellin could be
a potent immunostimulant and vaccine adjuvant for fish aquaculture.
Keywords: flagellin, immunostimulant, vaccine adjuvant, salmonids, cytokine, antimicrobial peptides, gene
expression, inflammatory response
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INTRODUCTION
Aquaculture accounts for more than half of the fish consumed
worldwide and contributes greatly to the supply of affordable
protein in developing countries (1). The farmed fish are kept
at high population densities that increase the risk of disease
outbreaks caused by infectious bacteria, viruses, parasites and
fungi (2–4), hence infectious disease is one of the major limiting
factors in aquaculture.Multiplemeasuresmust be taken to ensure
the health of these fish and the use of immune-stimulants and
vaccination represent two important strategies for controlling
diseases in aquaculture (2, 3, 5–13).
Fish have a strong innate immune system that can cope with
a large variety of infectious agents. However, many pathogens
have developed evasion mechanisms to resist innate immune
defenses, and in such cases the adaptive immune system, that
evolved for the first time in early vertebrates, must come into play
to fight these pathogens (8). The innate and adaptive immune
systems are cross-linked, and the magnitude and specificity of the
signals perceived by the innate immune cells following infection
or vaccination shape subsequent adaptive immune responses
(9).
Immune-stimulants are chemical compounds that activate
leukocytes and hence may render animals more resistant to
infections. The innate immune response is initiated upon
recognition of pathogen-associated molecular patterns (PAMPs),
such as double stranded RNA, flagellin, lipopolysaccharide (LPS)
and β-glucans (9, 14), by pattern recognition receptors (PRRs)
such as Toll-like receptors (TLR), C-type lectin receptors (CLRs),
NOD-like receptors (NLR) and RIG-I-like receptors (RLR) (15).
In the presence of PAMPs, the immune system will respond as
if challenged by a pathogenic microbe. Hence, PAMPs, when
administrated prior to an infection, may elevate defenses and
function as immune stimulants. They can also function as
adjuvants when formulated with vaccines, to elevate the specific
adaptive immune response (11–13).
Bacterial flagellin is the major structural protein in the
flagellum of Gram positive and negative bacteria (8, 16). Due
to its presence in diverse bacterial species and high abundance
in bacterial cells, flagellin is a potent PAMP and a major
target of the host immune system. Monomeric flagellin (30–60
kDa, dependent upon the taxa of the bacterium) contains in
general an N-terminal D0/D1, a middle D2/D3 and a C-terminal
D1/D0 domain. The last ∼40 amino acids of each terminus of
the flagellin molecule form the D0 domain. The D1 domain
constitutes the next ∼100 residues from the N-terminus and
50 residues from the C-terminus. The D0 and D1 domains are
key for assembly of the helical filamentous structure and hence
are highly conserved across different species of bacteria, and
contain primarily α-helical structures. In contrast the D2 and D3
domains have high sequence diversity and can be absent in some
bacterial species, such as B. cereus (17–20). The hypervariable
D2 and D3 domains are composed of β-sheets bearing adhesion-
like properties and are essential for flagellin immunogenicity
(16, 17).
In mammals, extracellular flagellin is recognized by TLR5
expressed by antigen-presenting cells and T cells (21, 22).
Mammalian TLR5 is a plasma membrane-localized PRR
(TLR5M) that possesses an extracellular domain with leucine-
rich repeats (LRRs), a transmembrane region, and a cytoplasmic
signaling domain termed the Toll/interleukin-1 receptor
homology (TIR) domain. Crystal structure analysis showed
that two flagellin molecules simultaneously bind two TLR5
receptors on the D1 domain, forming a 2:2 complex. In addition
to the D1 domain, deletion mutant experiments revealed
that the D0 domain is also required to produce maximum
TLR5-mediated signaling (17–19). The activation of TLR5
mediates the production and secretion of pro-inflammatory
cytokines, chemokines and other mediators for the development
of an effective immune response (21, 23). In rainbow trout
(Oncorhynchus mykiss) and other teleost species, two TLR5
genes are present in the genome (24–29). One (TLR5M)
encodes for an extracellular LRR domain, a transmembrane
region, and a cytoplasmic TIR domain as seen in mammalian
TLR5. The second encodes only the LRR in the extracellular
domain and hence is a soluble form of TLR5 (TLR5S). Trout
TLR5M is widely expressed in all tissues whereas TLR5S is
mainly expressed in liver (24, 25). Both the TLR5M and TLR5S
recognize flagellin from Vibrio anguillarum a Gram-negative
bacterium (24).
The evaluation of flagellin as a vaccine candidate, and as
a vaccine adjuvant have been examined in fish recently (16,
30–35). Flagellin has also been shown to induce non-specific
protection to a variety of bacterial pathogens in vivo in rainbow
trout (36). However, the immune pathways elicited and the
mechanisms responsible are largely unknown, with only few
pro-inflammatory genes and tissues studied (14, 15, 37).
A recombinant flagellin from the fish pathogen Yersinia
ruckeri (YRF) was produced in our lab and shown in vitro
to upregulate the transcript level of a large number of pro-
inflammatory cytokines, APPs, AMPs and members of the IL-
12 cytokine family in the monocyte/macrophage-like cell line,
RTS-11 (23). In the present study the immunomodulatory
effects of flagellin were explored further in vivo in several
major immune tissues, namely spleen, liver, gills and skin. In
teleost fish the kidney, spleen and liver are major systemic
lymphoid tissues containing many immune cell types that are
vital components for initiating immune reactions within the
immune system (38, 39). Mucosa-associated lymphoid tissues
(gut, gills, nares and skin) are also important to prevent invasion
of pathogens from the surrounding environment of the host (40–
42). Hence two systemic and two mucosa-associated tissues were
chosen for study of the immune-modulatory effects following
YRF injection in vivo. Our results show that YRF activates
a systemic inflammatory response and multiple antimicrobial
pathways in vivo. To pave the way for the use of YRF as an
immune stimulant or a vaccine adjuvant, we also investigated
the antigenicity of full-length YRF and the bioactivity of YRF
deletion mutants. The results showed that fish could produce
high serum antibody titres against flagellin after vaccination, and
that these antibodies recognize the middle D2/D3 domain of the
flagellin and can decrease flagellin bioactivity. However, deletion
of either the N-terminal, C terminal or themiddle domain of YRF
led to loss of the proinflammatory activity. The impact of these
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results on the potential use of flagellin as an immune-stimulant
or vaccine adjuvants in fish aquaculture is discussed.
MATERIALS AND METHODS
Experimental Fish
Healthy rainbow trout were bought from the Mill of Elrich Trout
Fishery (Aberdeenshire, Scotland, United Kingdom) and kept
in 1-m-diameter fiberglass tanks with recirculating freshwater
at 14◦C at the Scottish Fish Immunology Research Centre,
University of Aberdeen, UK. Fish were fed twice daily with a
commercial diet (EWOS) and were given at least 2 weeks to
acclimate before use. Routine screening of head kidney swabs
showed no bacterial presence (43).
Production of Recombinant Y. ruckeri
Flagellin and Its Mutants
The construct pTri-YRF for expression of full-length
recombinant Y. ruckeri flagellin (YRF) and the production
of YRF was described previously (23). The mutant YRF
constructs, YRF-N, YRF-C and YRF-NC, were prepared from
pTRI-YRF by PCR using the Q5 high fidelity enzyme (New
England Biolabs, United Kingdom) and re-ligation, using
primer pairs GCCAGTTCCGCTCATCACCAC/GGAACGGAA
GTTACCGTTAACCATC (YRF-N), GCCCATGGTATATCT
CCTTTGATTGT/GATAACCGCACGGCAGCCA (YRF-C),
and CAAGACTTTAATGCCGTTGAAATCGGT/GTTGAA
GCCAAAGGTTTTGACGTATTGA (YRF-NC), respectively.
Whilst the YRF-N and YRF-C have the C-terminal and N-
terminal D0/D1 domains deleted, respectively, the YRF-NC
has the middle D2/D3 removed and replaced with a GS linker
[SGGGGSGGGGSGGGGS, (44)]. All the muteins have a his-tag
(ASSAHHHHHHHHHH) at the C-terminus for purification.
A multiple alignment of YRF and its muteins is provided in
Figure S1. Following sequence confirmation, the transformation
of BL21 Star (DE3) competent cells (Invitrogen), induction of
recombinant protein production, purification under denaturing
conditions, refolding, re-purification under native conditions,
SDS-PAGE analysis of proteins and quantification of protein
concentration were as described previously (23).
Stimulation of RTS-11 Cells
The monocyte/macrophage-like cell line, RTS-11, from rainbow
trout spleen was cultured in Leibovitz (L-15) medium
(Invitrogen, United Kingdom) plus 30% fetal calf serum
(FCS; Labtech International, United Kingdom) and antibiotics
(100 U/ml penicillin and 100µg/ml streptomycin; Invitrogen,
UK) at 20◦C, and passaged as described previously (45). For
experiments, cells were collected by centrifugation (200 × g,
5min), re-suspended in L-15 containing 10% FCS to 1 x 106
cells/ml, and seeded into 12-well cell culture plates at 2 ml/well.
Overnight cell cultures were stimulated with 100 ng/ml YRF,
5µg/ml ultrapure lipopolysaccharide (LPS, Invivogen) from
E. coli 0111:B4, and 5µg/ml peptidoglycan (PGN, Invivogen)
purified from the Gram-positive bacterium Staphylococcus
aureus, for 1, 2, 4, 8, and 24 h. Subsequently the cells were
stimulated with different concentrations of YRF and its muteins
for 4 h. The stimulation was terminated by dissolving the cells
in TRI reagent (Sigma, United Kingdom). The RNA preparation
and cDNA synthesis was as described previously (23, 46).
Administration of YRF in vivo and Sampling
Twenty eight rainbow trout (∼210 g) were randomly divided into
two groups. Fish were injected intraperitoneally (ip) with 200 µl
of phosphate-buffered saline (PBS, pH 7.4) or PBS containing 10
µg of YRF per fish. The dose chosen was based on the finding that
50 ng/ml in vitro induces the highest gene expression changes in
most of the genes examined (23), and equates to 50 ng/g body
weight in vivo. Whilst this dose is at the low end of those used
previously in salmon and trout (10–50 µg per fish) (16, 36), the
results demonstrate it was highly effective. Seven fish per group
were killed at 6 and 24 h post injection, and the gills, skin, spleen
and liver were taken and homogenized in TRI reagent with 5mm
stainless steel beads using a TissueLyser II (Qiagen) as described
previously (46).
Real-Time PCR Analysis of Gene
Expression
Total RNA extraction, cDNA synthesis and real-time PCR
analysis of gene expression were as described previously (47, 48).
The expression of cytokines, antimicrobial peptides (AMPs),
acute phase proteins (APPs), complement components, arginase
genes, and suppressor of cytokine signaling (SOCS) genes as
well as the house keeping gene elongation factor-1α (EF-1α),
was examined. The primers for real-time PCR are given in
Table S1, with at least one primer per pair designed to cross an
intron to ensure genomic DNA could not be amplified under the
PCR conditions used. The expression of each gene was initially
normalized to that of EF-1α, and then shown as a fold change
by calculating the average expression level of the treated samples
divided by that of time-matched controls.
Immunization and Antiserum Preparation
Ten rainbow trout (∼200 g) were ip injected with 90 µg/fish
of YRF mixed with 0.2ml of complete Freund’s adjuvant (CFA,
Sigma, United Kingdom) (YRF+CFA). A control group of 10
fish was ip. injected with CFA alone. The fish were bled from the
caudal vein 3 months post immunization. Blood samples were
incubated at 4◦C overnight and then centrifuged at 5,000 rpm for
10min at 4◦C. Serum was collected and stored at −80◦C until
use.
Enzyme-Linked Immunosorbent Assay
(ELISA)
YRF-specific IgM antibody titres in serum samples were
determined by ELISA using mouse anti-trout IgM (clone I-
14) (49). Briefly, high binding capacity 96 well-plates (Thermo
scientific) were coated with 1,000 ng/well of YRF in coating buffer
(pH 9.0, 100mM NaHCO3, 12mM Na2CO3) for 2 h at 37
◦C
and washed 3 times with wash buffer (PBS containing 1% (w/v)
skimmed milk and 0.05% (v/v) Tween 20) and then blocked for
2 h at 37◦C with 5% (w/v) skimmed milk in wash buffer. Plates
were washed 3 times with wash buffer before addition of serum
samples. Individual fish serum was serially diluted 2-fold in 1%
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milk in 1X PBS. Each dilution was added to YRF coated plates
(50 µl/well) in duplicate and incubated at 4◦C overnight. Plates
were then washed 3 times with wash buffer and mouse anti-trout
IgM added (50 µl/well) and incubated for 2 h at 37◦C. After
washing 3 times with wash buffer, the detection antibody (goat
anti-mouse IgG labeled with horseradish peroxidase, Sigma, UK)
diluted 1:3,000 in 1X PBS, 1% milk was added (50 µl/well) and
incubated for 1 h at 37◦C. The plates were again washed 3 times
with wash buffer and developed by adding 50µl/well of 3, 3
′
, 5,5
′
-
Tetramethylbenzidine (TMB) Liquid Substrate, Supersensitive,
for ELISA (Sigma, UK) to each well for 30min. The reaction was
stopped by adding 50 µl/well of 0.5M sulphuric acid and the
color reaction read at 450 nm in an ELISA plate reader (SoftMax
Pr0 5.3). The antibody titres were determined as the reciprocal of
the maximal serum dilution that exceeded double the reading of
the negative control.
Neutralization Assay
The potential of antisera (see section Immunization and
Antiserum Preparation) to neutralize YRF bioactivity was test
in RTS-11 cells. Ten nanogram of YRF was mixed with 100
µl anti-YRF sera or control sera, or L-15 cell culture medium
and incubated at room temperature for 1 h. The samples were
then added (in quadruplicate) to each well of a 12-well plate
containing RTS-11 cells prepared as above (section Stimulation of
RTS-11 Cells). Amatched serum or L-15 sample without YRFwas
also added to RTS-11 cells to function as additional controls. The
incubation was terminated at 4 h by dissolving the cells in TRI
reagent R© (Sigma, United Kingdom). The expression of IL-1β1
and IL-1β2 was determined by RT-qPCR as described above.
Western Blot
The binding capacity of antisera from rainbow trout immunized
with YRF/CFA to YRF and its muteins was examined byWestern
blot analysis. The preparation of full-length YRF and its deletion
mutants YRF-N, YRF-C and YRF-NC was as described above
(section Production of Recombinant Y. ruckeri Flagellin and Its
Mutants). Four concentrations (1,000, 500, 250, and 125 ng) of
YRF and mutated proteins (∼1,000 ng) were separated by SDS-
PAGE. Another un-related recombinant flagellin (Flagellin-B)
prepared in a similar way as YRF was also included as a control.
Briefly, each sample was mixed with NuPAGE LDS Sample Buffer
(Invitrogen, United Kingdom) and 0.5% of 2-ME, boiled at 95◦C
for 15min, and loaded into the wells of a NuPAGETM NovexTM 4–
12% Bis-Tris Protein Gel (Invitrogen, United Kingdom), along
with SeeBlue R© Plus2 Pre-stained Protein marker (Invitrogen,
United Kingdom). The gel was run in 1X NuPAGE R© MES
SDS Running Buffer, at 200 Volts for 30min. The protein
gel was either stained with Imperial protein stain (Thermo
Scientific, UK), or transferred to Hybond R©-P polyvinylidene
difluoride (PVDF) membranes (Ambion) using a NuPAGE R©
Transfer Buffer system (Invitrogen) as recommended by the
manufacturer.
The PVDF membrane was blocked with 5% skimmed milk
in PBS (pH 7.2) containing 0.05% Tween 20 (PBST) for 1 h
and washed 3 times with 1X PBST. The membrane was then
incubated with the trout anti-YRF sera (diluted 1:1,000 in PBST)
overnight at 4◦C. After subsequent addition of mouse anti-
trout IgM (I-14 diluted 1:1,000 in PBST) and goat anti-mouse
IgG labeled with horseradish peroxidase (diluted 1:2,000, Sigma,
UK), with three washes between treatments, the membrane was
washed 5 times with 1X PBST and antibody binding detected
with a SuperSignal
TM
West Pico Chemiluminescent Substrate kit
(Thermo Scientific, United Kingdom).
Statistical Analysis
The data were statistically analyzed using the SPSS Statistics
package 24 (SPSS Inc., Chicago, Illinois). The analysis of
real-time PCR data was as described previously (47, 48). To
improve the normality of data, real-time quantitative PCR
measurements were scaled, with the lowest expression level
in a data set defined as 1, and log2 transformed. One way-
analysis of variance (ANOVA) and the Bonferroni post-hoc test
were used to analyse the gene expression data, with P < 0.05
between treatment and control groups considered significant.
Genes significantly modulated by YRF in vivo were selected
and their fold changes were log2 transformed and subjected to
hierarchical clustering analysis using the Morpheus program at
https://software.broadinstitute.org/morpheus.
RESULTS
Yersinia ruckeri Flagellin (YRF) Is the Most
Potent Bacterial Derived PAMP to Activate
Pro-Inflammatory Genes in RTS-11 Cells
LPS, PGN and flagellins are bacterial derived PAMPs that can
activate an inflammatory response in mammals and have the
potential to be used as an immune stimulant or vaccine adjuvants
in fish aquaculture. To compare the immune stimulatory potency
of these PAMPs, a fish macrophage-like cell line (RTS-11)
was incubated with an optimal dose (100 ng/ml, 23) of YRF,
or 50-fold higher dose (5,000 ng/ml) of ultrapure LPS and
PGN in a time course from 1 to 24 h. The expression of
major proinflammatory cytokines, IL-1β1-2 (50), TNFα1-3 (51),
and IL-6 (52) was examined. YRF rapidly activated all the
proinflammatory cytokines from 1 h-24 h, with a peak already
seen at 1 h for IL-1β2 and TNFα3, or at 4 h for other genes
(Figure 1) as seen previously (23). PGN also activated all the
inflammatory cytokines examined but at later time points, 4–
24 h for TNFα3, 8–24 h for IL-1β2, IL-6 and TNFα2, and 24 h
for IL-1β1 and TNFα1, and with less potency, eg IL-6 expression
was increased over 1,000-fold by YRF but only 10-fold by PGN
(Figure 1). Ultrapure LPS only slightly increased the expression
of TNFα3 at 24 h post stimulation and had no effect on the
other cytokines examined. The expression of proinflammatory
cytokines in samples stimulated with YRF at each time point was
higher than that with LPS from 1 to 24 h, and with PGN from 1
to 8 h. At 24 h, YRF stimulated samples expressed higher levels of
IL-1β1, IL-1β2 and IL-6, similar level of TNFα1, but lower levels
of TNFα2 and TNFα3, compared to PGN stimulated samples.
These expression profiles suggest that flagellin (YRF) is the most
potent PAMP tested in vitro to date in rainbow trout.
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FIGURE 1 | The expression of IL-1β1 (A), IL-1β2 (B), IL-6 (C), TNFα1 (D), TNFα2 (E), and TNFα3 (F), in response to stimulation by YRF, LPS and PGN in RTS-11
cells. RTS-11 cells were stimulated with 100 ng/ml of YRF, 5,000 ng/ml of ultrapure LPS or 5,000 ng/ml of PGN for 1, 2, 4, 8, and 24 h. The expression levels were
quantified by RT-qPCR and expressed as a fold change that was calculated as the average expression level of stimulated samples divided by that of the
time-matched controls. The results are presented as the average + SEM from four wells of cells. Differences between stimulated samples and controls were tested by
One way-ANOVA followed by the Bonferroni post hoc test. *p < 0.05, **p < 0.01, and ***p < 0.001.
Systematic Activation of Early
Pro-Inflammatory Pathways in vivo by YRF
After injection with YRF the fish behaved normally and no side-
effects were observed postmortem. The expression profiles of 120
trout genes were determined by RT-qPCR in spleen, liver, gills
and skin, at 6 h and 24 h post injection (hpi). The genes analyzed
included the known cytokines and SOCS genes in trout, and
genes of the acute phase response and antimicrobial defense. The
time points chosen were based on our previous study that showed
YRF activates a rapid increase in proinflammatory genes in vitro
(23). Thus the early response (at 6 hpi) and late response (at
24 hpi) were studied here. Detailed fold changes for each genes
analyzed are provided in Table S2.
Expression of the Main Proinflammatory Cytokines
The activation of TLR5 by flagellin triggers an inflammatory
response and activates the expression of fish immune relevant
genes in vitro (23). Therefore, following injection of YRF the
expression of major proinflammatory cytokines of the IL-1
family, IL-6 family and TNFα family was first examined. Five IL-
1 family members, three IL-1β paralogues (50), IL-18 (53) and
a novel IL-1 family member (nIL-1Fm) that antagonizes IL-1β
activity (54) are present in rainbow trout. The expression of IL-
1β1 and IL-1β2 was rapidly increased at 6 hpi in all tissues.
This activation subsided to control levels at 24 hpi with the
exception of IL-1β1 in the liver and IL-1β2 in the spleen where
the expression remained higher than the control (Figures 2A,B).
The expression of IL-1β3 was also rapidly induced but in a tissue
specific way at 6 h. Thus IL-1β3 expression was only induced
at 6 h in the gills and skin (Figure 2C). IL-18 expression was
induced only in spleen at 6 h and in the liver at 24 h (Table 1).
The expression of TNFα paralogues was also rapidly activated.
The expression profiles of both TNFα1 and TNFα2 were similar
and both were induced at 6 h in all four tissues examined
(Figures 2D,E). However, TNFα3 expression was only induced
at 6 hpi in the liver and skin (Figure 2F). The expression had
returned to control levels by 24 hpi for all genes.
IL-6 expression was rapidly and highly induced at 6 hpi in
the spleen, liver, gills and skin of injected fish (Figure 2G). The
heightened expression was retained in the spleen, liver and skin
to 24 hpi, albeit at lower levels. Similarly, the expression level
of IL-11 (55) was also significantly up-regulated in all the four
tissues examined at both time points, with an exceptionally high
induction of 1,776-fold at 6 hpi in the liver (Figure 2G). The
expression of M17 (56) was also induced but with lower fold-
induction. In contrast, CNTF (56) expression was refractory after
YRF injection in all tissues examined (Table 1).
IL-34 is a ligand for macrophage colony-stimulating factor-1
receptor, promotes the differentiation, proliferation, and survival
of monocytes, macrophages, and osteoclasts (57). Its expression
was also rapidly activated in spleen, liver and skin but only at 6
hpi (Table 1).
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FIGURE 2 | The activation of major proinflammatory cytokines in vivo by YRF. Rainbow trout were ip injected with 10 µg YRF/fish in PBS or PBS only as control. The
fish were killed, and spleen, liver, gills and skin samples were taken from each fish at 6 and 24 h post injection. The expression of IL-1β1 (A), IL-1β2 (B), IL-1β3 (C),
TNFα1 (D), TNFα2 (E), TNFα3 (F), IL-6 (G), IL-11 (H), and M17 (I) in each tissue was examined by RT-qPCR. A fold change was calculated as the average expression
level of YRF injected fish divided by that of time matched controls. The means + SEM of six fish are shown. Significant differences between injected fish and controls
were tested by one way-ANOVA followed by the Bonferroni post hoc test and are shown over the bars as; *p < 0.05, **p < 0.01, and ***p < 0.001.
The Expression of CXC Chemokines
Chemokines are chemotactic cytokines that regulate cell
trafficking during an immune response to recruit cells of the
immune system to a site of infection. The expression of 12 known
trout CXC chemokines (58) was examined. The proinflammatory
CXCL8/IL-8 expression was rapidly up-regulated in the spleen,
liver, gills and skin at 6 hpi, with up-regulation sustained in the
spleen and liver to 24 h (Figure 3B). CXCL_F4 expression was
also rapidly induced at 6 hpi and sustained to 24 hpi in all the
four tissues examined (Figure 3E). A transient up-regulation of
CXCL_F5 was seen in the spleen, liver and skin at the early
time point (Figure 3F). However, CXCL13 expression was up-
regulated at only the late time point in all tissues (Figure 3D).
In contrast, CXCL_F1c expression was downregulated in gills
at 24 hpi (Figure 3A). The expression of CXCL_F1a in the
spleen was irregular and no significant difference was observed
post YRF injection. The expression of other CXC chemokines,
CXCL_F1b, CXCL_F2, CXCL11_L1/γIP, CXCL12, and CXCL14,
was refractory (Figure 3C and Table 1).
The Expression of IL-12 Family
IL-12 family members are heterodimeric cytokines of α/β chains.
Genes for 6 active α-chains (p19, p28A, p28B, p35A1, p35A2,
and p35B) and 4 β-chains (p40B1, p40B2, p40C, and EBI3) have
been cloned in rainbow trout recently (44, 46, 59, 60). P19 (59)
expression was rapidly up-regulated at 6 hpi in the spleen, liver
and skin, and this was sustained in liver to 24 hpi (Figure 4A).
P35A1 (46) expression was only up-regulated in the liver at 6 h
and 24 h and in the skin at 6 hpi (Figure 4B). A transient up-
regulation was also seen with p35A2 in the spleen, liver, gills
and skin, and with EBI3 (61) in spleen (Figures 4C,D). The
expression of P28A (62), P28B and P40B1 was undetectable in
control samples of some tissues thus a fold change could not be
calculated. However, P40B1 expression was detected in the spleen
and liver samples at 6 hpi. No significant change was observed
in the expression of p28A, p28B, P40B2, and P40C (Table 1).
These expression profiles suggest specific IL-12, IL-23 and IL-35
isoforms may be induced by in vivo YRF administration.
The Expression of Adaptive Cytokines
Next the expression of cytokines involved in adaptive immunity
was examined, including IFNγ, IL-17 family, γ-chain cytokine
family and IL-20/22 to investigate if they weremodulated by YRF.
Both IFNγ1 and IFNγ2 were refractory to YRF stimulation in
all tissues (Figures 5A,B). IL-17A/F1a (63) expression was highly
up-regulated in the spleen and liver at 6 hpi and 24 hpi, but
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TABLE 1 | Fold change of transcript expression of selected genes in the spleen, liver, gills, and skin of fish injected ip with YRF.
Tissue Spleen Liver Gills Skin
Time 6h 24h 6h 24h 6h 24h 6h 24 h
IL-18 2.7*** 1.2 1.5 4.9*** 1.2 1.2 1.2 1.5
CNTF 0.5 0.9 0.8 0.6 1.0 0.6 1.0 0.6
P35B1 2.4 0.3 9.0 0.1 1.6 0.8 13.9 0.9
P28A 2.3 0.9 ND ND 13.4 1.5 7.5 0.4
P28B 5.9 2.0 ND ND ND ND ND ND
CXCL_F1a 22.2 103.0 1.5 1.0 0.6 0.7 1.6 0.8
CXCL_F1b 0.8 12.2 0.7 2.7 1.5 2.6 1.2 1.6
CXCL_F2 1.1 0.3 2.0 0.7 1.1 0.5 0.7 0.6
CXCL12a 0.9 0.4 1.8 0.4 0.8 1.6 0.9 1.5
CXCL12b 0.8 0.4 0.7 1.2 0.8 1.7 0.5 0.8
CXCL14 1.6 0.7 0.8 0.6 1.0 1.5 0.9 1.8
IFNγ1 1.3 0.7 1.0 3.8 0.3 0.9 0.2 0.4
IFNγ2 1.0 1.9 1.3 1.3 0.4 0.8 0.5 0.5
IL-17A/F1b ND 17.5 ND ND 1.2 0.6 0.3 0.6
IL-17A/F2a 0.6 0.7 1.9 11.4*** 0.4 0.5 0.2 0.4
IL-17A/F2b 0.8 1.1 2.0 2.2 0.9 1.0 0.5 0.9
IL-17A/F3 0.6 1.2 1.6 0.6 0.7 1.1 0.4 0.7
IL-17N 1.9 1.6 1.1 1.2 2.2 1.0 0.9 0.8
IL-17D 0.9 0.4 0.4 0.6 1.0 0.8 0.6 0.4
IL-2 1.1 0.7 1.2 1.1 1.0 0.6 1.0 1.1
IL-15 1.0 0.6 2.7*** 8.4*** 2.4* 0.7 1.2 1.0
IL-20 6.5 1.2 2.0 2.1 1.0 1.8 1.0 1.1
IL-21 1.6 0.9 1.7 1.4 1.5 0.8 0.9 0.9
IL-34 2.9*** 1.0 18.7*** 0.7 1.7 1.1 3.4*** 1.5
CISHb1 1.9 2.5 1.4 0.8 1.2 0.6 1.2 0.8
CISHb2 2.8 2.1 0.9 1.0 1.4 1.0 1.8 1.0
SOCS1B 1.2 1.4 0.5 2.8 0.8 1.2 0.9 1.3
SOCS2A1 2.4 3.7 1.1 0.3 1.3 1.8 1.0 1.3
SOCS2A2 0.6 0.5 3.3 0.2 1.4 1.2 0.7 0.8
SOCS2B 1.0 0.2 2.5 0.4 1.2 0.3 1.1 0.3
SOCS3B1 1.5 1.5 1.7 3.8 1.0 2.5 2.2 3.4
SOCS4 1.3 0.3 0.3 0.5 1.8 1.7 0.8 1.3
SOCS5A1 1.2 1.5 0.1 2.3 1.2 1.8 0.8 2.4
SOCS5A2 0.6 1.3 0.1 0.9 0.9 1.6 1.0 1.6
SOCS5B1 1.0 1.0 0.4 1.1 1.0 1.4 1.4 1.3
SOCS5B2 1.4 1.1 0.7 1.4 2.8 1.7 2.8 2.4
SOCS6B1 1.0 1.0 0.4 0.8 1.2 1.4 0.5 0.9
SOCS7A1 1.4 1.0 0.6 1.2 1.7 1.3 1.6 1.3
SOCS7A2 0.9 0.6 1.5 0.9 1.6 1.0 0.9 1.2
SOCS7B1 3.0 2.0 1.5 1.6 1.8 2.5 0.7 1.4
SAP2 1.8 1.8 0.9 1.7 1.1 0.9 0.9 2.1
β-defensin 1 ND 0.0 ND ND 1.8 0.3 0.9 1.2
β-defensin 2 3.1 5.4 1.5 0.8 0.8 0.7 0.3 1.2
β-defensin 3 4.4 1.3 0.9 1.8 7.6 3.3 3.0 1.3
LEAP2A 0.6 1.3 2.6 0.04*** 0.5 0.8 1.3 1.1
LEAP2B 0.8 0.2 1.2 0.05*** 1.3 0.6 0.7 0.6
Bf-2 1.9 1.9 1.7 1.4 1.4 0.9 0.2 0.5
(Continued)
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TABLE 1 | Continued
Tissue Spleen Liver Gills Skin
Time 6h 24h 6h 24h 6h 24h 6h 24 h
C1 inhibitor 2.8 1.1 1.0 0.7 0.8 1.2 0.8 1.3
C4 0.8 0.9 1.2 0.9 1.2 1.9 0.6 3.2
C5 7.8 1.4 1.3 1.3 1.1 0.7 0.2 1.2
C7-2 1.2 0.7 0.9 0.8 0.9 1.2 1.3 0.7
C8α 5.4 1.5 0.9 0.8 1.3 0.3 0.6 0.7
C8β 1.9 1.0 1.3 0.6 1.2 0.9 0.7 0.8
C8γ 0.9 0.5 1.2 0.6 1.2 1.4 1.1 0.8
C9 1.0 1.0 1.5 1.8 0.6 0.9 0.6 0.5
C3-3 4.0 3.7* 1.0 1.3 0.6 2.0 0.4 1.4
C3-4 6.2* 2.0 1.1 0.5 1.8 0.9 0.9 0.6
C3aR 1.8 1.7 1.5 1.5 2.5 1.1 1.9 1.6
The fold change was calculated as the average expression level of YRF injected fish divided by that of time-matched controls (N= 6). A number in bold with asterisks indicates significant
differences between YRF injected fish and controls as follows; * p < 0.05, **p < 0.01, and ***p < 0.001 (One-way-ANOVA with Bonferroni correction).
ND, not determined due to low expression levels.
ND*, detectable in YRF injected fish but not detectable in time-matched controls.
FIGURE 3 | The modulation of the expression of CXC chemokines in vivo by YRF. Rainbow trout were ip injected with YRF or PBS, sampled and analyzed as
described in Figure 2. The expression of CXCL_F1c (A), IL-8/CXCL8 (B), CXCL11_L1/γIP (C), CXCL13 (D), CXCL_F4 (E), and CXCL_F5 (F) was examined. A fold
change was calculated as the average expression level of YRF injected fish divided by that of time matched controls. The means + SEM of six fish are shown.
Significant differences between injected fish and controls were tested by one way-ANOVA followed by the Bonferroni post hoc test and are shown over the bars as;
*p < 0.05, **p < 0.01, and ***p < 0.001.
not in the gills and skin at both time points post YRF injection
(Figure 5C). IL-17A/F2a (64) expression was only upregulated
in the liver at 24 hpi (Table 1). Interesting, IL-17C1 (65) was
highly induced in the liver at 6 hpi and 24 hpi, and to a lesser
extent in the gills and skin at 6 hpi (Figure 5D). Similarly, IL-
17C2 expression was also induced in the liver at 6 hpi and
24 hpi and in the skin at 6 hpi (Figure 5E). The expression
of IL-1A/F1b, IL-17A/F2b, IL-17A/F3, IL-17N, and IL-17D was
refractory (Table 1). IL-22 (66) expression was rapidly induced
in the spleen, liver, gills and skin at 6 hpi, and this was sustained
in the liver to 24 hpi (Figure 5F). IL-20L (62) expression was
refractory (Table 1).
Upregulation of Th2 cytokines (67) was seen only in the
liver at 24 hpi, for IL-4/13A and IL-4/13B1 but not IL-4/13B2
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FIGURE 4 | The modulation of the expression of IL-12 family cytokines in vivo by YRF. Rainbow trout were ip injected with YRF or PBS, sampled and analyzed as
described in Figure 2. The expression of IL-23P19 (A), IL-12P35A1 (B), IL-12P35A2 (C), and EBI3 (D) was examined. A fold change was calculated as the average
expression level of YRF injected fish divided by that of time matched controls. The means + SEM of six fish are shown. Significant differences between injected fish
and controls were tested by one way-ANOVA followed by the Bonferroni post hoc test and are shown over the bars as; *p < 0.05, **p < 0.01, and ***p < 0.001.
(Figures 5G–I). IL-15 (68) expression was also seen up-regulated
in the liver at 6 and 24 hpi, and in the gills at 6 hpi (Table 1). The
expression of other γ-chain cytokines, IL-2 (69) and IL-21 (47)
was refractory in all tissues (Table 1).
The Expression of Anti-inflammatory Cytokines
The rapid but transient activation of major proinflammatory
cytokine gene expression suggests some negative regulatory
mechanisms must be activated by YRF. Thus, the expression of
several anti-inflammatory cytokines known in rainbow trout was
examined post YRF injection. The expression of both IL-10A and
IL-10B (70) was refractory (Figures 6A,B). A small induction was
seen in the liver at 24 hpi for TGFβ1A and at 6 hpi for TGFβ1B
(71) (Figures 6C,D). In addition, the expression of nIL-1Fm was
induced in the spleen, liver and skin at 6 hpi (Figure 6E).
The Expression of SOCS Genes
The SOCS family are key negative regulators of cytokine
and growth factor signaling, with 26 SOCS genes expressed
in rainbow trout [including an expressed pseudogene, (72)].
CISHa1 (73) was upregulated at 6 hpi but downregulated at 24
hpi in the liver (Figure 7A). CISHa2 was also up-regulated at 6
hpi and downregulated at 24 hpi in the liver, but in addition it
was upregulated at 6 hpi in the spleen, gills and skin (Figure 7B).
Both SOCS1 and SOCS3A were rapidly upregulated at 6 hpi, but
this had subsided at 24 hpi in all four tissues examined with the
exception of SOCS3A in the spleen (Figures 7C,D). SOCS3B2
expression was only increased in spleen at 6 hpi and in liver at
24 hpi (Figure 7E). The expression of both SOCS6A1, SOCS6A2,
and SOCS6B2 decreased at 6 hpi in the liver (Figures 7F–H
and Table 1). SOCS7B2 was increased in the liver at 6 and 24
hpi (Figure 7I). The expression of other SOCS genes, CISHb1-2,
SOCS1B, SOCS2A1-2, SOCS2B, SOCS3B1, SOCS4, SOCS5A1-
2/B1-2, SOCS6B1, and SOCS7A1-2, was refractory in all tissues
(Table 1).
Systematic Activation of Anti-microbial
Defense Pathways in vivo by YRF
To investigate potential antimicrobial pathways activated by YRF
injection, the expression of several known APPs, AMPs and
complement components was examined. SAA (74) expression
was upregulated in the spleen, liver and skin at 6 hpi, and in the
spleen, liver, gills and skin at 24 hpi (Figure 8A). SAP1 expression
was upregulated only in the spleen at 6 hpi (Figure 8B), and SAP2
was refractory (Table 1).
A systemic activation of cathelicidins, hepcidin and β-defensin
4 was observed in multiple tissues after YRF administration
(Figures 8C–F). CATH1 (75) expression was up-regulated in the
spleen, liver and skin at 6 hpi, and this was sustained in the skin
to 24 hpi (Figure 8C). The expression of CATH2 and hepcidin
(76) was induced and sustained from 6 hpi to 24 hpi in all the
four tissues examined (Figures 8D–E). It is noteworthy that the
induction of CATH2 and hepcidin in the liver, gills and skin was
higher at 24 hpi than that at 6 hpi. A small induction of β-defensin
4 (77) expression was observed in the spleen and liver but only
at 24 hpi (Figure 8F), whilst the expression of β-defensin 1–3
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FIGURE 5 | The modulation of the expression of adaptive cytokines in vivo by YRF. Rainbow trout were ip injected with YRF or PBS, sampled and analyzed as
described in Figure 2. The expression of IFNγ1 (A), IFNγ2 (B), IL-17A/F1a (C), IL-17C1 (D), IL-17C2 (E), IL-22 (F), IL-4/13A (G), IL-4/13B1 (H), and IL-4/13B2 (I),
was examined. A fold change was calculated as the average expression level of YRF injected fish divided by that of time matched controls. The means + SEM of six
fish are shown. Significant differences between injected fish and controls were tested by one way-ANOVA followed by the Bonferroni post hoc test and are shown
over the bars as; *p <0.05 and ***p < 0.001.
was refractory (Table 1). The expression of both LEAP2A and
LEAP2B was down-regulated in the liver at 24 hpi (Table 1).
The Expression of Complement Genes
in vivo After YRF Injection
The expression of 18 trout genes in the complement system (78)
was examined after YRF injection (Figure 9). C7-1 expression
was activated and sustained from 6 to 24 hpi in all four tissues
examined (Figure 9C). The expression of C1r and Bf-2 was
increased in spleen at 6 hpi (Figures 9A,D). C6 expression was
increased in the skin but only at 24 hpi (Figure 9B). Whilst the
expression of complement receptor CR1-like gene was increased
at 6 and 24 h hpi in both spleen and skin, it was only increased
at 6 hpi in the gills and at 24 hpi in the liver (Figure 9E),
C5aR expression was increased at 6 hpi in the spleen, and at 24
hpi in the liver and gills (Figure 9F). The expression of other
complement genes tested was refractory (Table 1)
Modulation of the Expression of Arginase
Genes and TLR5 in vivo by YRF
Macrophages are a first line of innate responders controlling and
organizing host defenses against pathogens and are essential for
maintaining homeostasis (79). They undergo specific activation
into functionally distinct phenotypes, such as M1 and M2 (80).
Arginase expression is an important marker of macrophage
activation, with four genes present in rainbow trout (81).
Whilst the expression of arginase 1a was upregulated at 6 and
24 hpi in the spleen, arginase 1b expression was refractory
(Figures 10A,B). Arginase 2a expression was rapidly activated
in the spleen, liver and skin at 6 hpi, and this was sustained
in the liver to 24 hpi (Figure 10C). Arginase 2b expression was
upregulated in both spleen and liver at 6 and 24 hpi (Figure 10D).
To further study the molecular mechanisms involved in the
above induction of immune genes by flagellin, the two types
of TLR5 genes (TLR5M and TLR5S, 24) present in trout were
examined. The expression of TLR5M and TLR5S was detectable
in all the tissues. However, there was no significant impact of
YRF on the expression of TLR5M in any tissue (Figure 10E).
Interestingly, TLR5S expression was significantly up-regulated in
all tissues at 6 hpi and this was maintained to 24 hpi in liver, gills
and skin (Figure 10F).
Clustering Analysis of Genes Modulated by
YRF in vivo
The genes that showed significant changes after YRF injection
were subjected to hierarchical clustering analysis that revealed a
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FIGURE 6 | The modulation of the expression of anti-inflammatory cytokines genes in vivo by YRF. Rainbow trout were ip injected with YRF or PBS, sampled and
analyzed as described in Figure 2. The expression of IL-10A (A), IL-10B (B), TGFβ1a (C), TGFβ1b (D), and nIL-1Fm (E) was examined. A fold change was calculated
as the average expression level of YRF injected fish divided by that of time matched controls. The means + SEM of six fish are shown. Significant differences between
injected fish and controls were tested by one way-ANOVA followed by the Bonferroni post hoc test, and are shown over the bars as; *p < 0.05 and ***p < 0.001.
time effect upon gene expression, with the gills and skin showing
a similar response (Figure 11). Three major expression profiles
(clusters A-C) of genes were observed after YRF injection. Cluster
A included the major proinflammatory cytokines (IL-1β, TNFα,
IL-6, IL-11, IL-17C, IL-12P35A, and IL-23P19), chemokines
(CXCL8 and CXCL_F4-5), anti-inflammatory genes (TGFβ1B,
CISHa, SOCS-1A, and SOCS3A) and TLR5S. These genes
were rapidly induced at 6 hpi by YRF in all or most of
the tissues but had decreased at 24 hpi (Figures 2–7, 10 for
detail), suggesting rapid albeit transient activation. Cluster B,
including IL-17A/F1a, EBI3, arginase-1 and several complement
genes, was also rapidly induced but mainly in the spleen.
Cluster C included the cytokines IL-4/13, IL-15, IL-17A/F2a,
IL-18, and TGFβ1a, arginase-2, several complement genes and
SOCS genes, APP and AMPs (Figure 11). This cluster of
genes showed higher expression at 24 hpi, especially in the
liver.
Antibody Response to YRF Vaccination in
Rainbow Trout
Low titres (average of 6) of anti-YRF IgM antibodies were
detected by ELISA in the sera 3 months-post injection with
CFA (Control serum). The YRF-specific IgM antibody titres were
markedly increased to 130,253 (average of 10 fish, p < 0.001)
in fish immunized with YRF/CFA (Anti-serum) (Figure 12A).
When 10 ng of YRF was incubated with cell culture medium
(L-15), anti-serum or control serum for 1 h, it could still
significantly activate the expression of IL-1β1 and IL-1β2.
However, the fold change of the anti-serum treated YRF was
lower than YRF incubated with L-15 or with control serum
(Figures 12B,C). These results show that YRF-specific antibodies
are induced by flagellin immunization, and that the antiserum
can decrease flagellin bioactivity.
Anti YRF Antibody Reacts Against the
Middle D2/D3 Domain
Full-length YRF contains N-terminal D0/D1 domains, middle
unstructured D2/D3 domains and C terminal D0/D1 domains.
To investigate the binding sites/domains of the anti-YRF
antibodies produced in rainbow trout, three mutants were
produced with the N-terminal deleted (YRF-C), middle
domain deleted (YRF-NC) and the C-terminal deleted (YRF-N)
(Figure 13A). The YRF and its mutants had expected sizes of
45.4, 33.6, 29.2 and 30.9 kDa for YRF, YRF-N, YRF-NC, and
YRF-C, respectively, and were successfully produced as shown
by SDS-PAGE after Imperial protein staining (Figure 13B).
Western blot analysis revealed that the antibodies produced after
YRF immunization reacted with full-length YRF, as well as the
mutant proteins with the middle D2/D3 domain retained (ie
YRF-N and YRF-C), but lost the reactivity against YRF-NC with
the middle D2/D3 domains deleted. Furthermore, the antiserum
did not react against an unrelated flagellin (flagellin-B) from
an unrelated fish bacterial pathogen (Figure 13C). This data
shows that the middle D2/D3 domain of YRF contains the
major antigenic determinants recognized by the host (rainbow
trout), and that the his-tag (ASSAHHHHHHHHHH) did not
contribute significantly to YRF immunogenicity.
Mutation of YRF Abrogates YRF
Proinflammatory Activity
To directly compare the proinflammatory activity of YRF and
its mutants, a dose-response analysis on a molar basis was
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FIGURE 7 | The modulation of the expression of SOCS genes in vivo by YRF. Rainbow trout were ip injected with YRF or PBS, sampled and analyzed as described in
Figure 2. The expression of CISHa1 (A), CISHa2 (B), SOCS1 (C), SOCS3A (D), SOCS3B2 (E), SOCS6A1 (F) SOCS6A2 (G) SOCS6B2 (H) SOCS7B2 (I) was
examined. A fold change was calculated as the average expression level of YRF injected fish divided by that of time matched controls. The means + SEM of six fish
are shown. Significant differences between injected fish and controls were tested by one way-ANOVA followed by the Bonferroni post hoc test, and are shown over
the bars as; *p < 0.05, **p < 0.01, and ***p < 0.001.
undertaken, using RTS-11 cells stimulated for 4 h. An initial
analysis revealed that the mutants lost their ability to induce
inflammatory gene expression. Thus, different (increased) dose
ranges were chosen, e.g,. 2–20,000 pM for YRF, 2,000–200,000
pM for YRF-N and YRF-C, and 200-200,000 pM for YRF-NC.
As expected, YRF was able to upregulate the expression of all
genes tested, including IL-1β2, IL-6, CXCL-8, TNFα3, and SAA
at all doses tested (2–20,000 pM) (Figure 14A). However, all the
YRF mutants lost the ability to upregulate the biomarker gene
expression at all the doses tested (Figures 14B–D).
DISCUSSION
Using an in vitro fish macrophage model, we have demonstrated
that, compared to LPS and peptidoglycan, flagellin is a
particularly potent inflammatory trigger, in terms of activation
of proinflammatory cytokine gene expression. Therefore, the
immune stimulatory effects of flagellin were studied in vivo
in an important model fish species, the rainbow trout. After
ip injection with the recombinant flagellin YRF, from the fish
pathogen Yersinia ruckeri, a transient systemic inflammation was
activated, along with multiple antimicrobial pathways. Tissue-
specificity of the response was also observed. High antibody titres
could be induced by flagellin, and these antibodies were shown to
react against the middle D2/D3 domains (demonstrated using a
variety of muteins), and to neutralize the bioactivity of flagellin.
Interestingly, the bioactivity was retained only with full-length
YRF. These results are discussed in the context of innate host
responses to flagellin, host/pathogen interactions, and the use
of flagellin as an immune stimulant or vaccine adjuvant in fish
aquaculture.
A Transient Systemic Activation of
Inflammation
To use a PAMP, such as a flagellin, as an immunostimulant
or a vaccine adjuvant in a fish species, it is necessary to first
understand the early events of the host response, the activation of
inflammatory responses and anti-microbial defense mechanisms.
In this study we used a targeted approach to determine the impact
of YRF on selected immune relevant genes as a means to gain
in-depth information on these events in our model species, the
rainbow trout.
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FIGURE 8 | The activation of APPs and AMPs in vivo by YRF. Rainbow trout were ip injected with YRF or PBS, sampled and analyzed as described in Figure 2. The
expression of SAA (A), SAP1 (B), CATH1 (C), CATH2 (D), hepcidin (E), and β-defensin-4 (F), was examined. A fold change was calculated as the average expression
level of YRF injected fish divided by that of time matched controls. The means + SEM of six fish are shown. Significant differences between injected fish and controls
were tested by one way-ANOVA followed by the Bonferroni post hoc test, and are shown over the bars as; *p < 0.05, **p < 0.01, and ***p < 0.001.
FIGURE 9 | The activation of complements in vivo by YRF. Rainbow trout were ip injected with YRF or PBS, sampled and analyzed as described in Figure 2. The
expression of complement genes C1r (A), C6 (B), C7-1 (C), Bf-1 (D), CR1 like (E), and C5aR (F) was examined. A fold change was calculated as the average
expression level of YRF injected fish divided by that of time matched controls. The means + SEM of six fish are shown. Significant differences between injected fish
and controls were tested by one way-ANOVA followed by the Bonferroni post hoc test, and are shown over the bars as; **p < 0.01 and ***p < 0.001.
Following YRF administration multiple proinflammatory
cytokines, including IL-1β, TNFα, IL-6, IL-11, M17, IL-17C,
IL-12, IL-22, IL-23, and chemokines (CXCL8, and CXCL_F4-
5) were induced by 6 hpi in all or most of the tissues
examined but had decreased by 24 hpi. A similar response was
also observed for several anti-inflammatory genes, including
nIL-1Fm, IL-35 and the type II SOCS family genes (CISHa,
SOCS1, and SOCS3A) that function intracellularly. However, the
anti-inflammatory cytokines IL-10A and IL-10B were refractory,
and TGFβ1 was only induced to a small extent in the liver
although several proinflammatory cytokine genes were highly
induced. These expression profiles suggest a rapid but transient
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FIGURE 10 | The modulation of the expression of arginase genes and TLR5 in vivo by YRF. Rainbow trout were ip injected with YRF or PBS, sampled and analyzed
as described in Figure 2. The expression of arginase 1a (A), arginase 1b (B), arginase 2a (C), arginase 2b (D), TLR5M (E), and TLR5S (F) in each tissue was
examined by RT-qPCR. A fold change was calculated as the average expression level of YRF injected fish divided by that of time matched controls. The means +
SEM of six fish are shown. Significant differences between injected fish and controls were tested by one way-ANOVA followed by the Bonferroni post hoc test, and are
shown over the bars as; **p < 0.01 and ***p < 0.001.
systemic inflammatory host response is elicited after YRF
injection.
The huge early induction (three orders of magnitude) of IL-
1β2 and IL-6 in the spleen, and IL-11, IL-17C1, and IL-23P19
in liver is noteworthy. Trout IL-1β is known to induce the
expression of itself and other inflammatory cytokines, eg TNF-
α (51), IL-6 (52), IL-11 (55), IL-17C2 (65), IL-23P19 (61), IL-
34 (57), and chemokines, eg CXCL8_L1 (IL-8), CXCL11_L1,
CXCL_F4, and CXCL_F5 (58). Trout IL-6 has been shown
to have effects on macrophages and B cells and promote the
expression of AMP genes, eg, hepcidin, CATH2 and LEAP2, and
complement genes (52), but has little effects on the expression
of proinflammatory cytokines. Although there are no bioactivity
studies reported for trout IL-11, IL-17C, and IL-23, it is possible
to assume their function from other fish species (eg IL-17C) and
mammals, although it should be noted that fish IL-17C genesmay
have arisen from an ancestral gene that gave rise to mammalian
IL-17C and IL-17E/IL-25 (65). Hence, the expression of many of
the proinflammatory cytokines and other immune genes may be
attributed to the early induction of IL-1β or IL-6. However, the
high level induction of IL-11, IL-17C1 and IL-23P19 expression
is in the liver where IL-1β expression is moderate. Furthermore,
IL-1β preferentially induces the expression of IL-17C2 but not
IL-17C1 that is highly induced by YRF. These expression profiles
may suggest multiple cells or signaling pathways are activated by
YRF injection in different tissues.
The lack of response of Th1 pathway genes (82) in all
tissues was surprising. This included IFNγ1, IFNγ2, and IFNγ
inducible chemokine CXCL11_L (58), and the cytokines IL-
2 and IL-21 that induce IFNγ expression (47, 69). However,
the Th17 marker genes IL-17A/F1 and IL-17A/F2 (63) were
induced in spleen and/or liver, whilst the Th2 cytokines IL-
4/13A and IL-4/13B (67) and Treg pathway cytokine TGFβ1 were
induced in liver only. The implications of these responses will
be discussed later in terms of the potential adjuvant effects of
flagellin.
Systemic Activation of Multiple
Anti-microbial Defense Pathways by IP
Injection of YRF
In response to flagellin injection, fish rapidly increase the
expression of multiple APPs, AMPs and complement genes in
addition to proinflammatory cytokines and chemokines. These
molecules may play an important role in mediating protection
against intruding pathogens. Cytokines such as IL-1β and IL-6
induce the expression of APPs, AMPs and complement genes,
and may indirectly induce their upregulation following YRF
injection.
APPs are involved in diverse defensive functions, such as
induction of cytokine synthesis, leukocyte recruitment, activation
of epithelial immunity, opsonisation and antiviral activity. Trout
SAA is strongly induced in a wide variety of immune-relevant
tissues by infection or challenge with PAMPs and can be
detected in all primary defense barriers and in mononuclear
cells of head kidney, spleen and liver, suggesting a role in local
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FIGURE 11 | Clustering analysis of genes modulated by YRF in vivo. Rainbow trout were ip injected with YRF or PBS, sampled and gene expression analyzed. Genes
significantly modulated (at least onetime point/tissue) were selected for analysis. The fold changes were log2 transformed and subjected to hierarchical clustering
using the Morpheus program. Three major expression profiles (clusters A–C) of genes are apparent.
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FIGURE 12 | Antibody response to YRF vaccination. (A) YRF-specific IgM antibody titer. Rainbow trout were immunized with CFA+YRF or CFA alone as control. YRF
specific IgM antibody was detected by ELISA in sera collected 3 months post immunization. The mean+SEM of 10 fish from each group are shown. Neutralization of
YRF activated IL-1β1 (B) and IL-1β2 (C) expression. YRF was incubated with sera from CFA+YRF immunized trout (Anti-serum), or sera from CFA immunized fish
(Control serum), or cell culture medium (L-15) for 1 h before addition to RTS-11 cells. Matched serum or L-15 samples without YRF were also added to RTS-11 cells
as controls. After 4 h the incubation was terminated and the expression of IL-1β1 and IL-1β2 determined by RT-qPCR as described above. The bridge and asterisk
connected bars indicate a statistical difference (P < 0.05).
FIGURE 13 | (A) Schematic representation of YRF and its mutants. Full-length
YRF contains the N-terminal D0/D1 domains, the middle unstructured D2/D3
domain and the C terminal D1/D0 domains. Three mutants with the N-terminal
deleted (YRF-C), middle domain deleted (YRF-NC) and the C-terminal deleted
(YRF-N) were produced. (B) SDS-PAGE and (C) Western blot analysis of YRF
and its mutants. YRF1000, 500, 250, and 125 indicate amount (ng) of protein
loaded. An unrelated flagellin protein (Flagellin-B) was also included as a
control. The protein gel was stained with Imperial protein stain (B) or detected
by Western blotting (C) using antisera from rainbow trout immunized with YRF
+ CFA. M = SeeBlue plus 2 protein marker. Red arrows indicate a negative
signal.
defense (74). AMPs, such as hepcidins, cathelicidins and β-
defensins play an important role in defense against microbial
invasion (75–77). Although the primary mode of action of
antimicrobial peptides has been described as lysis of pathogens,
they have also been reported to exert a number of other
effects such as immune modulation. For example, mammalian
hepcidin regulates iron homeostasis, and cathelicidins have
been implicated in wound healing, angiogenesis, and other
innate immune mechanisms (52). The complement system plays
a central role in early pathogen defense by opsonization of
pathogens, release of anaphylatoxins, and formation of the
membrane attack complex (78). Interestingly, the peak induction
of APPs, AMPs and complement genes was delayed, with highest
expression observed at 24 hpi in the liver, gills and skin.
The expression modulation patterns suggest that YRF injection
activates an early inflammation leading to activation of systemic
antimicrobial defenses that may account for the non-specific
protection seen in rainbow trout against different bacteria after
YRF injection (36). Thus flagellin may have potential to be used
as an immunostimulant in fish aquaculture.
Interestingly, arginase 1 was up-regulated in only spleen
whilst arginase 2 was induced in the spleen, liver and skin. In
mammals, macrophages have functionally distinct phenotypes
defined by two activation states, M1 and M2, which represent
two polar ends of a continuum exhibiting pro-inflammatory
and tissue repair activities, respectively (80). Arginase is one
of the key components driving the molecular mechanisms
involved in macrophage polarization. Arginase 1 is induced
by the Th2 cytokines IL-4 and IL-13, and is considered a
M2 marker in mammals (80). However, arginase 2 may be
a more relevant marker of M2 cells in teleost fish (81). In
rainbow trout arginase 1 expression is highly modulated by
PAMPs and pro-inflammatory cytokines whilst arginase 2 is
induced by the fish specific Th2 cytokine IL-4/13 (81). Whether
the increased expression of arginases is due to increased
trafficking of arginase expressing macrophages, or is induced
in situ directly by flagellin or by upregulated cytokines, or
both, remains to be determined. The co-expression of arginase
2 and IL-4/13 in the liver may suggest the activation of a
homeostatic tissue repair mechanism after an acute inflammatory
event.
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FIGURE 14 | Dose-response of biomarker gene expression in response to YRF and its mutants. RTS-11 cells was stimulated with different concentrations of YRF (A),
and its mutants YRF-NC (B), YRF-N (C), and YRF-C (D) for 4 h. The gene expression of IL-1β2, IL-6, CXCL-8, TNFα3, and SAA was determined by qPCR, and
expressed as a fold change relative to the control samples. The means + SEM of four independent samples are shown. Note: the expression of all the genes was
significantly different from controls in YRF stimulated samples only.
Tissue Specific Responses to IP Injection
of YRF
The clustering analysis revealed a tissue specific gene expression
profile, with the liver showing modulation of the largest number
of immune genes, especially at 24 hpi. The liver is the central
metabolic organ that must actively prevent the induction of
immune responses to gut-derived antigens, and neo-antigens that
are generated by the liver’s metabolic and detoxification activities.
In addition, gut-derived microbes and microbial products must
be removed from the circulation to prevent systemic immune
activation. Thus, the liver serves as an important barrier
between the gut and the circulation. Both the maintenance
of hepatic tolerance and the initiation of inflammation are
mainly mediated by the liver-resident antigen-presenting cells
(APCs) that are constantly exposed to gut-derived dietary
and microbial antigens (83). These APCs include liver-resident
dendritic cells, liver-resident macrophages, Kupffer cells and the
liver sinusoidal endothelial cells, and semi-professional APCs,
such as hepatocytes and hepatic stellate cells. These cells are
instrumental for the downregulation of immune responses in
the liver and the initiation of liver inflammation/ recruitment
of leukocytes to the liver (83). An acute inflammatory response
was clearly initiated in liver by YRF injection of trout, as shown
by the up-regulation of many inflammatory genes. Interestingly,
the major specific primary targets of TLR5 agonists (eg flagellin)
in liver of rodents and primates are hepatocytes (84). The most
inducible genes in trout liver were IL-11, IL-23P19 and IL-
17C1 that were induced over 1,000 fold at 6 hpi, and remained
elevated to 24 hpi. However, in vitro IL-11 was only moderately
induced by YRF in the macrophage cell line RTS-11 and head
kidney (HK) cells that contain macrophages (as well as other
leucocytes), IL-23P19 was induced in RTS-11 but not HK cells
and IL-17C1 was not induced in either RTS-11 or HK cells (23).
This difference in immune gene induction may suggest different
cells in liver are involved in the YRF response.Whether these cells
are hepatocytes or other APCs remains to be determined in fish.
SAA (APP) and CATH2 (AMP) were massively induced
by YRF in liver, especially at the late time point. Their later
upregulation may suggest that these genes are affected by the
cytokines (IL-11, IL-23, and IL-17C1) induced early by YRF,
alone or in combination.
The best way for mass application of immunostimulants in
aquaculture is their use as dietary additives (9). The activation
of an inflammatory response and multiple defense pathways by
YRF injection in liver suggests that flagellin could be delivered
via the diet if formulated to protect its degradation in the gastric
and intestinal tract of fish.
The Middle D2/D3 Domain Is the Main
Target of the Host Immune Response
A strong IgM response was induced after YRF immunization in
rainbow trout. The antiserum could decrease the bioactivity of
YRF, and our results showed that these antibodies reacted against
the middle D2/D3 domain. However, an antibody response is
not desirable when flagellin is used as an immunostimulant or
vaccine adjuvant, since the antibodies may affect the flagellin
stimulatory effect on repeat exposure. Although there is no direct
experimental evidence, the binding of antibodies may block
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flagellin binding to its receptor, or opsonize the flagellin for
its removal. A strong antibody response to flagellin may also
adversely affect the specific response to the target antigen (s)
when used as an vaccine adjuvant. To mitigate against these
undesirable effects, a flagellin could be modified to remove the
middle D2/D3 domain to eliminate or reduce the antibody
response but retain the immunostimulatory effects (17, 20).
Full-Length YRF Is Necessary for
Activation of Inflammation: An Evasion
Mechanism of the Pathogen?
The immunological impact of flagellin stimulation has driven
several bacterial pathogens to evolve mechanisms to escape
TLR5-mediated host defense. For example, Listeria shuts off
flagellin expression at the host temperature of 37◦C, and in the
major food-borne pathogen Campylobacter jejuni and the gastric
pathogen Helicobacter pylori, flagellin structural changes lead to
the evasion of TLR5 activation (85). The activation of TLR5
requires a specific structural conformation in flagellin that is
mainly defined in the D1 domain although other domains may
contribute. Thus, flagellin that has been modified by removing
the middle D2/D3 domain can retain its TLR5 activation capacity
(20). It is also worth noting that different host species may have
different structural requirements for flagellin to activate TLR5
signaling, as shown in mammals and birds (85). Our results
showed that only full-length YRF is bioactive; any changes at the
N-terminal, the C-terminal or the middle D2/D3 domain led to
loss of bioactivity in vitro. This data suggests that TLR5 signaling
in rainbow trout requires a structural conformation maintained
by full-length YRF.
YRF originates from Yersinia ruckeri, a flagellated Gram-
negative enterobacterium that is the causative agent of enteric
redmouth disease (ERM), a hemorrhagic septicemia that
primarily affects farmed salmonid fish species (23). A bacterin
vaccine against ERM prepared from motile serovar 1 Y. ruckeri
strains was the first commercialized fish vaccine. This vaccine
has been used worldwide for several decades and has proven
an effective and economical means for the control of ERM.
It appears that the flagellum is necessary for vaccine-mediated
immunity and that the prolonged use of this vaccine has provided
a selective force driving the emergence of nonmotile variants
associated with disease outbreaks in previously vaccinated fish,
independently in the USA and Europe (86). These cases suggest
that flagellin is an important virulence factor of motile Y. ruckeri
and an important immune determinant of the host immune
response and vaccine mediated protection. The requirement of
a full-length YRF for TLR5 activation in rainbow trout may
benefit this motile pathogen to evade TLR5 activation. It is
perceivable that the required structural conformation might be
easily disturbed by protease cleavage after flagellin release, or by
binding of other proteins or antibodies in vivo or at the mucosal
surface of the fish host.
In contrast to the singlemembrane form of TLR5 inmammals,
teleost fish (including salmonids) possess one membrane TLR5
and one secreted TLR5. Both TLR5M and TLR5S bind flagellin
(24). The modulation of TLR5M and TLR5S expression by
flagellin is controversial in fish. In rainbow trout, YRF did
not induce the expression of TLR5M and TLR5S in vitro in
either RTS-11 cells or in primary HK cells (23) and only
up-regulated the expression of TLR5S in vivo, as shown in
this study. A strong up-regulation of TLR5S has also been
reported in Atlantic salmon after vaccinationwithV. anguillarum
flagellin (16). In channel catfish, both TLR5M and TLR5S
are upregulated by recombinant Y. ruckeri flagellins in vitro
in primary HK macrophages and in vivo in HK (87). It is
noteworthy that fish TLR5M and TLR5S can be upregulated
by bacterial infection and by LPS (24, 87). Clearly the fish
species-specific modulation of TLR5 expression in response to
flagellin needs further research in different species using pure
flagellins.
In the present study rainbow trout TLR5S expression was
induced rapidly in vivo in all the tissues examined at 6 hpi and
this was sustained in the liver, gills and intestine to 24 hpi when
the expression of most proinflammatory cytokines activated by
flagellin had subsided. The different expression patterns suggest
that trout TLR5S may function as a negative feedback regulator
of flagellin signaling, that is induced by flagellin and competes
with TLR5M for flagellin binding. This notion is in contrast to the
hypothesis that the inducible TLR5S amplifies membrane TLR5-
mediated cellular responses in a positive feedback fashion (24),
and warrants further investigation to understand how flagellin
signaling is regulated in fish.
Using Flagellin as an Immunostimulant or
Vaccine Adjuvant
Flagellin is a potent activator of innate immune responses
in vitro in different fish species (23, 87). Our results in rainbow
trout show that a transient systemic inflammation is activated
following flagellin injection, leading to the activation of multiple
antimicrobial pathways in both internal and mucosal tissues.
Furthermore, non-specific protection against bacterial infections
can be elicited in rainbow trout after flagellin injection (36).
All these data suggest that flagellin can be used as a potent
immunostimulant or a vaccine adjuvant in fish aquaculture.
Themost convenient use of immunostimulants in aquaculture
is as diet additives. Due to its protein nature, flagellin must be
reformulated to avoid degradation in the gastric and intestinal
tract, and should be modified by removing the antigenic D2/D3
domain. Although it is not possible to obtain functional mutants
with YRF, research by others (85, 88) and by us suggests that
some flagellins are malleable and functional mini-flagellins can
be generated.
A vaccine-mediated immune response involves the
integration of three distinct signals delivered in sequence. Signal
1 is antigen recognition; signal 2 is co-stimulation provided by
APC; and signal 3 is the cytokine milieu that drives lymphocyte
differentiation and expansion. Adjuvants can be distinguished
between signal 1 facilitators and signal 2 facilitators. The signal
1 facilitators influence the fate of the vaccine antigen in time,
place, and concentration, ultimately improving its immune-
availability, while signal 2 facilitators provide the co-stimulatory
signals during antigen recognition (8).
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Flagellin can be a signal 1 facilitator as it can induce the
expression of proinflammatory cytokines and chemokines eg
CXCL8 and CXCL13, which promote the recruitment of T
and B lymphocytes and APCs to the site of immunization,
thus maximizing the chances of antigen-specific lymphocytes
encountering their cognate antigens. It may also function as a
signal 2 facilitator by activating APCs to express co-stimulatory
receptors. Furthermore, flagellin in combination with other TLR
agonists may function as a signal 3 facilitator by induction of
cytokines for specific T helper cell subsets. For example, the
induction of IL-4/13 expression by flagellin in rainbow trout may
facilitate a Th2 type response, whilst IL-12 and IL-23 expression
may drive Th1 and Th17 responses, respectively. It is widely
accepted that as an adjuvant, flagellin can induce an enhanced
antigen-specific immune response in different animals (31–35,
88).
In vaccine development for fish aquaculture, flagellin could
be added to existing bacterin or inactivated viral vaccines by
mixing or conjugating to enhance their immunogenicity. It could
also be formulated in subunit vaccines as fusion proteins. The
uniqueness of flagellin as an adjuvant is its ability to be easily
incorporated into a DNA vaccine. DNA vaccines induce both
early and late immune responses in fish and more than 20
different viral DNA vaccines have been developed experimentally
for prophylactic use in fish. The rhabdoviridae DNA vaccines (eg
VHSV and IHNV) have shown high levels of efficacy, athough
with some viruses only moderate to low efficacies are seen (12).
Thus, incorporation of adjuvants into these less effective vaccines
may be needed to provide adequate protection. As a protein
adjuvant, flagellin can be easily incorporated into a DNA vaccine
as a DNA construct, or with the target antigen physically linked
to the N- or C-terminal or replacing the D2/D3 domain. Thus,
flagellin adjuvants have the potential to open new avenues for
efficacious vaccine development for fish aquaculture.
CONCLUSION
Of three bacterial PAMPs (LPS, peptidoglycan and flagellin)
tested in this study, flagellin (YRF) was the most potent activator
of proinflammatory cytokine expression in vitro. YRF injection of
trout initiated a transient systemic inflammatory response with
key pro-inflammatory cytokines (IL-1β, TNFα, IL-6, and IL-11
etc.) and chemokines (CXCL_F4 and CXCL-8), induced rapidly
(6 hpi) but subsiding quickly in multiple tissues. Consequently,
several anti-microbial pathways were activated systemically with
heightened expression of APPs (SAA), AMPs (cathelicidins and
hepcidin) and complement genes in multiple tissues, which was
sustained to 24 hpi in the liver and mucosal tissues. The Th17
cytokines IL-17A/F1a and IL-17A/F2a were also induced in the
liver and spleen (IL-17A/F1a only), and Th2 cytokine IL-4/13
was induced in the liver. However, the anti-inflammatory IL-10
and Th1 cytokine IFNγ were refractory. The secreted TLR5S
was induced by flagellin in all tissues examined whilst the
membrane TLR5M was refractory, suggesting that TLR5S may
function as a negative feedback regulator. Trout liver appeared
to be an important organ responding to flagellin stimulation,
with marked induction of IL-11, IL-23P19, IL-17C1, SAA and
cathelicidin-2. YRF induced a strong antibody response, with
the generated antibodies binding the middle domain of YRF
and able to neutralize YRF bioactivity. Intact YRF is necessary
for its bioactivity, with deletion of either the N-terminal, C
terminal or middle domain of YRF leading to functional loss.
This study adds to the growing literature suggesting that flagellin
could be a potent immunostimulant and vaccine adjuvant for fish
aquaculture.
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